{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:52:47Z","timestamp":1781747567072,"version":"3.54.5"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10787-026-02268-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:24:31Z","timestamp":1779276271000},"page":"4031-4046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-target therapeutic potential of Flavokawain A in rheumatoid arthritis: A mechanistic and translational perspective"],"prefix":"10.1007","volume":"34","author":[{"given":"Goparaju","family":"Kavya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vancha","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palakurthi","family":"Yanadaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharfuddin","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"10","key":"2268_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105244","volume":"9","author":"N Abu","year":"2014","unstructured":"Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Zulfadli AJ et al (2014b) Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. PLoS ONE 9(10):e105244","journal-title":"PLoS ONE"},{"issue":"10","key":"2268_CR2","doi-asserted-by":"publisher","first-page":"e105244","DOI":"10.1371\/journal.pone.0105244","volume":"9","author":"N Abu","year":"2014","unstructured":"Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Zulfadli AJ, Omar AR, Sulaiman MR, Abdullah MP, Alitheen NB (2014a) Flavokawain a induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. PLoS ONE 9(10):e105244","journal-title":"PLoS ONE"},{"issue":"1","key":"2268_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-102","volume":"13","author":"N Abu","year":"2013","unstructured":"Abu N, Ho WY, Yeap SK, Akhtar MN, Abdullah MP, Omar AR et al (2013) The Flavokawains: uprising medicinal chalcones. Cancer Cell Int 13(1):102. https:\/\/doi.org\/10.1186\/1475-2867-13-102","journal-title":"Cancer Cell Int"},{"issue":"7","key":"2268_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2174\/187152061507150713111557","volume":"15","author":"N Abu","year":"2015","unstructured":"Abu N, Mohamed NE, Yeap SK, Lim KL, Akhtar MN, Zulfadli AJ et al (2015) In vivo anti-tumor effects of Flavokawain A in 4T1 breast cancer cell-challenged mice. Anticancer Agents Med Chem 15(7):905\u2013915","journal-title":"Anticancer Agents Med Chem"},{"issue":"7","key":"2268_CR5","first-page":"1199","volume":"10","author":"N Abu","year":"2015","unstructured":"Abu N, Mohameda NE, Tangarajoo N, Yeap SK, Akhtar MN, Abdullah MP et al (2015) In vitro toxicity and in vivo immunomodulatory effects of flavokawain A and flavokawain B in Balb\/C mice. Nat Prod Commun 10(7):1199\u20131202","journal-title":"Nat Prod Commun"},{"key":"2268_CR6","unstructured":"BDMARDs in the Management of Rheumatoid Arthritis [Internet]. [cited 2026 Apr 16]. Available from: https:\/\/www.physio-pedia.com\/BDMARDs_in_the_Management_of_Rheumatoid_Arthritis#:~:text=bDMARDs can have fewer adverse effects than,be encouraged to report any side effects"},{"key":"2268_CR7","volume-title":"Rheumatoid arthritis","author":"K Chauhan","year":"2026","unstructured":"Chauhan K, Jandu JS, Brent LH, Al-Dhahir MA (2026) Rheumatoid arthritis. StatPearls,  Treasure Island"},{"issue":"1","key":"2268_CR8","doi-asserted-by":"publisher","first-page":"102038","DOI":"10.1016\/j.berh.2025.102038","volume":"39","author":"KS Cheema","year":"2025","unstructured":"Cheema KS, Bit Mansour A, Raychaudhuri SP (2025) What\u2019s new on the horizon for rheumatoid arthritis management. Best Pract Res Clin Rheumatol 39(1):102038","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"2268_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M et al (2023b) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther 8(1):68","journal-title":"Signal Transduct Target Ther"},{"key":"2268_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01331-9","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M et al (2023a) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01331-9. (Springer Nature)","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2268_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01568-y","volume":"15","author":"M Dong","year":"2024","unstructured":"Dong M, Li G, Geng G, Ming M, Xu Y (2024) Flavokawain A suppresses the malignant progression of neuroblastoma in vitro depending on inactivation of ERK\/VEGF\/MMPs signaling pathway. Discov Oncol 15(1):677","journal-title":"Discov Oncol"},{"issue":"3","key":"2268_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rdc.2017.04.003","volume":"43","author":"V van Drongelen","year":"2017","unstructured":"van Drongelen V, Holoshitz J (2017) Human Leukocyte Antigen-disease associations in rheumatoid arthritis. Rheum Dis Clin North Am 43(3):363\u2013376","journal-title":"Rheum Dis Clin North Am"},{"key":"2268_CR13","unstructured":"Fern K (2025) Piper methysticum [Internet]. [cited 2025 Sep 22]. Available from: https:\/\/tropical.theferns.info\/viewtropical.php?id=Piper+methysticum"},{"issue":"2","key":"2268_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183\u2013196. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.006","journal-title":"Immunity"},{"key":"2268_CR15","unstructured":"Flavokawain A (2025) [cited 2025 Sep 23]. Available from: https:\/\/www.tcichemicals.com\/IN\/en\/p\/H1571"},{"issue":"3","key":"2268_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B (2019) Methotrexate mechanism in treatment of rheumatoid arthritis. Jt Bone Spine 86(3):301\u2013307","journal-title":"Jt Bone Spine"},{"issue":"4","key":"2268_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.70030","volume":"52","author":"S Gayen","year":"2025","unstructured":"Gayen S, Roy S, Laishram D, Bandyopadhyay SN, Mukherjee S (2025) Flavokawain A ruthenium-p-cymene complex-induced apoptosis by the modulation of PI3K\/\u03b2-Catenin\/HER2\/PARP signalling in lung cancer. Clin Exp Pharmacol Physiol 52(4):e70030","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"2268_CR18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.it.2021.03.002","volume":"42","author":"N Hannemann","year":"2021","unstructured":"Hannemann N, Apparailly F, Courties G (2021) Synovial macrophages: from ordinary eaters to extraordinary multitaskers. Trends Immunol 42(5):368\u2013371. https:\/\/doi.org\/10.1016\/j.it.2021.03.002","journal-title":"Trends Immunol"},{"key":"2268_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683990","volume":"8","author":"B Hern\u00e1ndez-Breijo","year":"2021","unstructured":"Hern\u00e1ndez-Breijo B, Plasencia-Rodr\u00edguez C, Navarro-Comp\u00e1n V, Garc\u00eda-Hoz C, Nieto-Ga\u00f1\u00e1n I, Sobrino C et al (2021) Remission Induced by TNF inhibitors plus methotrexate is associated with changes in peripheral Na\u00efve B cells in patients with rheumatoid arthritis. Front Med 8:683990","journal-title":"Front Med"},{"issue":"2","key":"2268_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jcmm.13973","volume":"23","author":"YC Hseu","year":"2019","unstructured":"Hseu YC, Yang TY, Li ML, Rajendran P, Mathew DC, Tsai CH et al (2019) Chalcone flavokawain A attenuates TGF-\u03b21-induced fibrotic pathology via inhibition of ROS\/Smad3 signaling pathways and induction of Nrf2\/ARE-mediated antioxidant genes in vascular smooth muscle cells. J Cell Mol Med 23(2):775\u2013788","journal-title":"J Cell Mol Med"},{"key":"2268_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116006","volume":"170","author":"SY Hung","year":"2024","unstructured":"Hung SY, Chen JL, Tu YK, Tsai HY, Lu PH, Jou IM et al (2024) Isoliquiritigenin inhibits apoptosis and ameliorates oxidative stress in rheumatoid arthritis chondrocytes through the Nrf2\/HO-1-mediated pathway. Biomed Pharmacother 170:116006","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"2268_CR22","doi-asserted-by":"publisher","first-page":"22123","DOI":"10.1021\/acsomega.4c00368","volume":"9","author":"Z Jabbar","year":"2024","unstructured":"Jabbar Z, Irfan HM, Alamgeer, Ullah A, Mahmoud MH, Batiha GE et al (2024) Trans-chalcone (1\u20133-diphenyl-2-propen-1-one) as a therapeutic candidate in joint inflammation via reduction of TNF-\u03b1, IL-1\u03b2, IL-6, and IL-17 in rodents: an in vivo study by RT-PCR and ELISA analysis. ACS Omega 9(20):22123\u201322135","journal-title":"ACS Omega"},{"key":"2268_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22030462","author":"DD Jandial","year":"2017","unstructured":"Jandial DD, Krill LS, Chen L, Wu C, Ke Y, Xie J et al (2017b) Induction of G2M arrest by Flavokawain A, a Kava chalcone, increases the responsiveness of HER2-overexpressing breast cancer cells to Herceptin. Molecules. https:\/\/doi.org\/10.3390\/molecules22030462","journal-title":"Molecules"},{"issue":"3","key":"2268_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/molecules22030462","volume":"22","author":"DD Jandial","year":"2017","unstructured":"Jandial DD, Krill LS, Chen L, Wu C, Ke Y, Xie J, Hoang BH, Zi X (2017a) Induction of G2M arrest by flavokawain a, a kava chalcone, increases the responsiveness of HER2-overexpressing breast cancer cells to herceptin. Molecules 22(3):462","journal-title":"Molecules"},{"key":"2268_CR25","doi-asserted-by":"publisher","first-page":"117305","DOI":"10.1016\/j.taap.2025.117305","volume":"498","author":"L Jin","year":"2025","unstructured":"Jin L, Jiang X, Li Y, Xiang S, Pei R, Lu Y et al (2025) Flavokawain a induces cell cycle arrest through CDT1-dependent p27 regulation and synergizes with venetoclax in acute myeloid leukemia. Toxicol Appl Pharmacol 498:117305","journal-title":"Toxicol Appl Pharmacol"},{"key":"2268_CR26","doi-asserted-by":"crossref","unstructured":"Jing S, Wan J, Wang T, He Z, Ding Q, Sheng G et al. (2022) Flavokawain A alleviates the progression of mouse osteoarthritis\u202f: an in vitro and in vivo study. pp 1\u201315","DOI":"10.3389\/fbioe.2022.1071776"},{"issue":"1","key":"2268_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02491-1","volume":"23","author":"KW Kim","year":"2021","unstructured":"Kim KW, Kim BM, Won JY, Min HK, Lee KA, Lee SH et al (2021) Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis. Arthritis Res Ther 23(1):124. https:\/\/doi.org\/10.1186\/s13075-021-02491-1","journal-title":"Arthritis Res Ther"},{"key":"2268_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.fct.2013.05.031","volume":"58","author":"DJ Kwon","year":"2013","unstructured":"Kwon DJ, Ju SM, Youn GS, Choi SY, Park J (2013) Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-\u03baB and AP-1 activation in RAW 2647 macrophages. Food Chem Toxicol 58:479\u2013486","journal-title":"Food Chem Toxicol"},{"key":"2268_CR29","doi-asserted-by":"crossref","unstructured":"Laskou F, Konzett V, Smolen JS, Edwards CJ, Aletaha D, van der Heijde D, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2026; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003496726001433","DOI":"10.1016\/j.ard.2026.02.024"},{"issue":"1","key":"2268_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.intimp.2013.03.026","volume":"16","author":"DS Lee","year":"2013","unstructured":"Lee DS, Li B, Im NK, Kim YC, Jeong GS (2013) 4,2\u2032,5\u2032-Trihydroxy-4\u2032-methoxychalcone from Dalbergia odorifera exhibits anti-inflammatory properties by inducing heme oxygenase-1 in murine macrophages. Int Immunopharmacol 16(1):114\u2013121","journal-title":"Int Immunopharmacol"},{"key":"2268_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.toxrep.2014.02.002","volume":"1","author":"X Li","year":"2014","unstructured":"Li X, Xu X, Ji T, Liu Z, Gu M, Hoang BH et al (2014) Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicol Reports 1:2\u201311","journal-title":"Toxicol Reports"},{"issue":"39","key":"2268_CR32","doi-asserted-by":"publisher","first-page":"41809","DOI":"10.18632\/oncotarget.6166","volume":"6","author":"X Li","year":"2015","unstructured":"Li X, Yokoyama NN, Zhang S, Ding L, Liu H, Lilly MB et al (2015) Flavokawain A induces deneddylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Oncotarget 6(39):41809\u201341824","journal-title":"Oncotarget"},{"issue":"1","key":"2268_CR33","first-page":"379","volume":"19","author":"J Li","year":"2020","unstructured":"Li J, Zheng L, Yan M, Wu J, Liu Y, Tian X et al (2020) Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer. Oncol Lett 19(1):379\u2013387","journal-title":"Oncol Lett"},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"1033003","DOI":"10.3389\/fphar.2022.1033003","volume":"13","author":"ST Liang","year":"2022","unstructured":"Liang ST, Chen C, Chen RX, Li R, Chen WL, Jiang GH et al (2022) Michael acceptor molecules in natural products and their mechanism of action. Front Pharmacol 13:1033003","journal-title":"Front Pharmacol"},{"issue":"1","key":"2268_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02500-4","volume":"41","author":"S Liu","year":"2022","unstructured":"Liu S, Liu Z, Piao C, Zhang Z, Kong C, Yin L et al (2022a) Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer. J Exp Clin Cancer Res 41(1):293","journal-title":"J Exp Clin Cancer Res"},{"key":"2268_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030496","author":"Z Liu","year":"2022","unstructured":"Liu Z, Song L, Xie J, Simoneau AR, Uchio E, Zi X (2022b) Chemoprevention of urothelial cell carcinoma tumorigenesis by dietary Flavokawain A in UPII-Mutant Ha-ras transgenic mice. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14030496","journal-title":"Pharmaceutics"},{"issue":"12","key":"2268_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1158\/1940-6207.CAPR-13-0219","volume":"6","author":"Z Liu","year":"2013","unstructured":"Liu Z, Xu X, Li X, Liu S, Simoneau AR, He F et al (2013) Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res 6(12):1365\u20131375","journal-title":"Cancer Prev Res"},{"issue":"04","key":"2268_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4172\/2155-9899.1000160","volume":"04","author":"CJ Malemud","year":"2013","unstructured":"Malemud CJ (2013) Intracellular signaling pathways in rheumatoid arthritis. J Clin Cell Immunol 04(04):160","journal-title":"J Clin Cell Immunol"},{"key":"2268_CR39","first-page":"81","volume":"119","author":"J Mucke","year":"2022","unstructured":"Mucke J, Simon HU, Burmester R\u00fcdigerG (2022) The safety of antirheumatic drugs. Dtsch Arztebl Int 119:81\u201387","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"2268_CR40","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/tx5003194","volume":"27","author":"SC Narayanapillai","year":"2014","unstructured":"Narayanapillai SC, Leitzman P, O\u2019Sullivan MG, Xing C (2014) Flavokawains a and B in Kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL\/6 mice. Chem Res Toxicol 27(10):1871\u20131876","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"2268_CR41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3892\/etm.2016.3045","volume":"11","author":"C Negrei","year":"2016","unstructured":"Negrei C, Bojinca V, Balanescu A, Bojinca M, Baconi D, Spandidos DA et al (2016) Management of rheumatoid arthritis: impact and risks of various therapeutic approaches. Exp Ther Med 11(4):1177\u20131183","journal-title":"Exp Ther Med"},{"key":"2268_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.06.039","volume":"191","author":"L Niu","year":"2016","unstructured":"Niu L, Ding L, Lu C, Zuo F, Yao K, Xu S et al (2016) Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. J Ethnopharmacol 191:350\u20139","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"2268_CR43","volume":"16","author":"SJ Patil","year":"2024","unstructured":"Patil SJ, Thorat VM, Koparde AA, Bhinge SD, Chavan DD, Bhosale RR (2024) Unlocking the future: new biologic therapies for rheumatoid arthritis. Cureus 16(10):e72486","journal-title":"Cureus"},{"issue":"9","key":"2268_CR44","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3109\/13880209.2015.1107104","volume":"54","author":"KD Pinner","year":"2016","unstructured":"Pinner KD, Wales CTK, Gristock RA, Vo HT, So N, Jacobs AT (2016) Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes. Pharm Biol 54(9):1503\u20131512","journal-title":"Pharm Biol"},{"issue":"11","key":"2268_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/toxins13110745","volume":"13","author":"P Rajendran","year":"2021","unstructured":"Rajendran P, Alzahrani AM, Priya Veeraraghavan V, Ahmed EA (2021) Anti-apoptotic effect of flavokawain A on ochratoxin-A-induced endothelial cell injury by attenuation of oxidative stress via PI3K\/AKT-mediated Nrf2 signaling cascade. Toxins 13(11):745","journal-title":"Toxins"},{"issue":"10","key":"2268_CR46","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/138955707782110105","volume":"7","author":"MMM Santos","year":"2007","unstructured":"Santos MMM, Moreira R (2007) Michael acceptors as cysteine protease inhibitors. Mini Rev Med Chem 7(10):1040\u20131050","journal-title":"Mini Rev Med Chem"},{"issue":"5","key":"2268_CR47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0031-9422(00)00346-0","volume":"55","author":"V Seidel","year":"2000","unstructured":"Seidel V, Bailleul F, Waterman PG (2000) (Rel)-1beta,2alpha-di-(2,4-dihydroxy-6-methoxybenzoyl)-3beta, 4alpha-di-(4-methoxyphenyl)-cyclobutane and other flavonoids from the aerial parts of Goniothalamus gardneri and Goniothalamus thwaitesii. Phytochemistry 55(5):439\u2013446","journal-title":"Phytochemistry"},{"issue":"11","key":"2268_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2165\/00023210-200216110-00002","volume":"16","author":"YN Singh","year":"2002","unstructured":"Singh YN, Singh NN (2002) Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 16(11):731\u2013743","journal-title":"CNS Drugs"},{"key":"2268_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943846","volume":"12","author":"L Song","year":"2022","unstructured":"Song L, Mino M, Yamak J, Nguyen V, Lopez D, Pham V et al (2022) Flavokawain A reduces tumor-initiating properties and stemness of prostate cancer. Front Oncol 12:943846","journal-title":"Front Oncol"},{"issue":"8","key":"2268_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/cbin.70036","volume":"49","author":"YK Talati","year":"2025","unstructured":"Talati YK, Dagar N, Gaikwad AB (2025) Flavokawain A attenuated chronic kidney disease: evidence from network pharmacology and experimental verification. Cell Biol Int 49(8):1015\u20131028","journal-title":"Cell Biol Int"},{"key":"2268_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1602967","volume":"13","author":"A Taldaev","year":"2025","unstructured":"Taldaev A, Svotin AA, Obukhov SI, Terekhov RP, Selivanova IA (2025) Modification of biopharmaceutical parameters of flavonoids: a review. Front Chem 13:1602967","journal-title":"Front Chem"},{"issue":"6","key":"2268_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1158\/1940-6207.CAPR-08-0165","volume":"1","author":"Y Tang","year":"2008","unstructured":"Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X (2008a) Effects of the Kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res 1(6):439\u2013451","journal-title":"Cancer Prev Res"},{"issue":"6","key":"2268_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1158\/1940-6207.CAPR-08-0165","volume":"1","author":"Y Tang","year":"2008","unstructured":"Tang Y, Simoneau AR, Xie J, Shahandeh B, Zi X (2008b) Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res 1(6):439\u2013451","journal-title":"Cancer Prev Res"},{"issue":"9_Supplement","key":"2268_CR54","first-page":"1258","volume":"68","author":"Y Tang","year":"2008","unstructured":"Tang Y, Simoneau A, Zi X (2008c) Induction of Bim expression by Flavokawain A, a novel chalcone from the kava plant, is necessary for its apoptotic effect in androgen-independent prostate cancer cell lines. Cancer Res 68(9_Supplement):1258","journal-title":"Cancer Res"},{"key":"2268_CR55","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/bs.acr.2025.06.004","volume":"168","author":"KD Tew","year":"2025","unstructured":"Tew KD, Townsend DM, Zhang L, Zhang X, Ye Z, Zhang J (2025) Michael addition drugs and cancer. Adv Cancer Res 168:196\u2013220","journal-title":"Adv Cancer Res"},{"issue":"6","key":"2268_CR56","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bmc.2017.01.049","volume":"25","author":"C Thieury","year":"2017","unstructured":"Thieury C, Lebouvier N, Le Gu\u00e9vel R, Barguil Y, Herbette G, Antheaume C et al (2017) Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives. Bioorg Med Chem 25(6):1817\u20131829","journal-title":"Bioorg Med Chem"},{"key":"2268_CR57","doi-asserted-by":"publisher","first-page":"174480692312040","DOI":"10.1177\/17448069231204051","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Chen T, Shuqing Z, Yu L, Chen S, Lu H et al (2023) Xanthohumol relieves arthritis pain in mice by suppressing mitochondrial-mediated inflammation. Mol Pain 19:17448069231204052","journal-title":"Mol Pain"},{"key":"2268_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115342","volume":"294","author":"S Wang","year":"2022","unstructured":"Wang S, Du Q, Sun J, Geng S, Zhang Y (2022) Investigation of the mechanism of Isobavachalcone in treating rheumatoid arthritis through a combination strategy of network pharmacology and experimental verification. J Ethnopharmacol 294:115342","journal-title":"J Ethnopharmacol"},{"key":"2268_CR59","volume":"2021","author":"Y Wang","year":"2021","unstructured":"Wang Y, Su C, Zhang B, Niu Y, Ren R, Zhao X et al (2021) Biological activity, hepatotoxicity, and structure-activity relationship of Kavalactones and Flavokavins, the two main bioactive components in Kava (Piper methysticum). Evid Based Complement Alternat Med 2021:6851798","journal-title":"Evid Based Complement Alternat Med"},{"key":"2268_CR60","doi-asserted-by":"publisher","first-page":"120387","DOI":"10.1016\/j.jep.2025.120387","volume":"353","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang J, Liu W, Zhang L, Li R, Wang Y et al (2025) Signal pathways in the treatment of rheumatoid arthritis with traditional Chinese medicine. J Ethnopharmacol 353:120387","journal-title":"J Ethnopharmacol"},{"key":"2268_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113288","volume":"186","author":"K Wang","year":"2020","unstructured":"Wang K, Zhang W, Wang Z, Gao M, Wang X, Han W et al (2020) Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism pathway. J Pharm Biomed Anal 186:113288","journal-title":"J Pharm Biomed Anal"},{"key":"2268_CR62","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou H, Liu L (2018) Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem 158:502\u2013516","journal-title":"Eur J Med Chem"},{"key":"2268_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1049875\/full","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Okano T, Gon T, Yoshida N, Fukumoto K, Yamada S et al (2022) Difficult-to-treat rheumatoid arthritis: current concept and unsolved problems. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.1049875\/full","journal-title":"Front Med"},{"issue":"4","key":"2268_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/ar3067","volume":"12","author":"CK Wong","year":"2010","unstructured":"Wong CK, Chen DP, Tam LS, Li EK, Yin YB, Lam CWK (2010) Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 12(4):R129. https:\/\/doi.org\/10.1186\/ar3067","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2268_CR65","doi-asserted-by":"publisher","first-page":"747","DOI":"10.5530\/ijper.20257348","volume":"59","author":"L Wu","year":"2025","unstructured":"Wu L, Qin F, Zhao C, Hou P (2025) Cardioprotective role of flavokawain A against isoproterenol-induced acute myocardial infarction in rats via modulation of NF-?B\/HO-1\/NQO-1 pathways. Indian J Pharm Educ Res 59(2):747\u2013756. https:\/\/doi.org\/10.5530\/ijper.20257348","journal-title":"Indian J Pharm Educ Res"},{"key":"2268_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154687","volume":"112","author":"T Xiao","year":"2023","unstructured":"Xiao T, Bao J, Tian J, Lin R, Zhang Z, Zhu Y et al (2023) Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT. Phytomedicine 112:154687","journal-title":"Phytomedicine"},{"key":"2268_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175981","volume":"958","author":"T Xiao","year":"2023","unstructured":"Xiao T, Gao D, Gu X, Zhang Y, Zhu Y, Zhang Z et al (2023) Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-\u03b2 signaling pathway and CXCL12\/CXCR4 axis. Eur J Pharmacol 958:175981","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2268_CR68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.5530\/ijper.20257346","volume":"59","author":"X Xiao","year":"2025","unstructured":"Xiao X, Liu S, Chen G, Cao C (2025) Anti-arthritic effect of traditional Chinese medicinal compound Bavachalcone on Freund\u2019s complete adjuvant-induced rheumatoid arthritis in rats. Indian J Pharm Educ Res 59(2):727\u2013737","journal-title":"Indian J Pharm Educ Res"},{"issue":"8_Supplement","key":"2268_CR69","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2011-4629","volume":"71","author":"X Xu","year":"2011","unstructured":"Xu X, Liu Z, Li X, Liu S, Zi X (2011) Abstract 4629: Ultra performance liquid chromatography (UPLC)-tandem mass spectrometry (MS\/MS) method for analysis and pharmacokinetic study of flavokawain A, a novel chalcone from the kava plant, in mice. Cancer Res 71(8_Supplement):4629. https:\/\/doi.org\/10.1158\/1538-7445.AM2011-4629","journal-title":"Cancer Res"},{"key":"2268_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3476212","volume":"2020","author":"HL Yang","year":"2020","unstructured":"Yang HL, Yang TY, Gowrisankar YV, Liao CH, Liao JW, Huang PJ et al (2020) Suppression of LPS-induced inflammation by chalcone Flavokawain A through activation of Nrf2\/ARE-mediated antioxidant genes and inhibition of ROS\/NF\u03baB signaling pathways in primary splenocytes. Oxid Med Cell Longev 2020:3476212","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2268_CR71","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00432-020-03253-3","volume":"146","author":"C Yiannis","year":"2020","unstructured":"Yiannis C, Huang K, Tran AN, Zeng C, Dao E, Baselyous O et al (2020) Protective effect of kava constituents in an in vitro model of oral mucositis. J Cancer Res Clin Oncol 146(7):1801\u20131811","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2268_CR72","first-page":"16","volume":"30","author":"J Yusuf","year":"2024","unstructured":"Yusuf J, Rofiq A, Hermaya A, Islami M (2024) Use of biological disease-modifying antirheumatic drugs (bDMARD) therapy in rheumatoid arthritis: a review of side effects and immunological mechanisms: English. Asian Multidiscip Res J Econ Learn 30(1):16\u201322","journal-title":"Asian Multidiscip Res J Econ Learn"},{"issue":"14_Supplement","key":"2268_CR73","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2016-2182","volume":"76","author":"W Zhang","year":"2016","unstructured":"Zhang W, Morris J, Piperdi S, Guo Y, Ji T, Yang R et al (2016) Abstract 2182: Flavokawain A and B from Kava extract exhibits low toxicity and up-regulates tumor suppressor miRNAs in human osteosarcoma cells. Cancer Res 76(14_Supplement):2182. https:\/\/doi.org\/10.1158\/1538-7445.AM2016-2182","journal-title":"Cancer Res"},{"issue":"13_Supplement","key":"2268_CR74","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2017-2125","volume":"77","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Zhang W, Zaphiros N, Du X, Koirala P, Roth M et al (2017) Abstract 2125: Flavokawain A, a Kava chalcone, inhibits growth and invasion of human osteosarcoma cells by targeting Skp2. Cancer Res 77(13_Supplement):2125. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-2125","journal-title":"Cancer Res"},{"issue":"1","key":"2268_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32428-9","volume":"8","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zvi YS, Batko B, Zaphiros N, O\u2019Donnell EF, Wang J et al (2018) Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma. Sci Rep 8(1):14294. https:\/\/doi.org\/10.1038\/s41598-018-32428-9","journal-title":"Sci Rep"},{"key":"2268_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790122","author":"J Zhao","year":"2021","unstructured":"Zhao J, Guo S, Schrodi SJ, He D (2021) Molecular and cellular heterogeneity in rheumatoid arthritis:  mechanisms and clinical implications. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.790122","journal-title":"Front Immunol"},{"issue":"8","key":"2268_CR77","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-04-3803","volume":"65","author":"X Zi","year":"2005","unstructured":"Zi X, Simoneau AR (2005) Flavokawain A, a novel chalcone from Kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res 65(8):3479\u20133486","journal-title":"Cancer Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02268-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02268-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02268-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:16:39Z","timestamp":1781745399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02268-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02268-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}